Pharmacist's Letter

61 - 75 of 82 Results

Sort Results:

Guideline: Diagnosis and Management of ADHD in Children and Adolescents (ICSI) (Updated 2012) November 2009

Article: Some poison control centers are now reporting a higher rate of adverse reactions with Vyvanse (lisdexamfetamine) September 2008

Article: Stimulants work better than Strattera for treating ADHD in kids September 2008

Article: launch a "new and improved" formulation just before a drug gets generic competition September 2008

Other: Atomoxetine (Strattera) vs Methylphenidate for ADHD September 2008

Chart: New Formulations of Old Drugs September 2008

Other: Safety Concerns of Vyvanse September 2008

Article: Patients often ask about the right way to use patches July 2008

Article: whether cardiac testing is required for children taking ADHD drugs June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008

Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008

Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008

Patient Education: Patient Handout to Go Along with Your MedGuide for ADHD Drugs June 2008

Article: Sparlon and Daytrana, two new drugs for ADHD February 2006